We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a pu... Bausch & Lomb, headquartered in Laval, Quebec, Canada, is the fourth-largest vision care company by sales in the United States and the market leader in consumer vision care in India and China. The firm, which was previously a subsidiary under parent company Bausch Health, was spun off to become a public company once again in May 2022. The firm reports in three segments-vision care and consumer (60% of revenue), surgical (20%), and ophthalmic pharmaceuticals (20%). The company is geographically diversified, with 48% of revenue in the Americas, 30% from EMEA, and 22% from Asia-Pacific countries. Show more
The major U.S. index futures are currently pointing to roughly flat open on Tuesday, with stocks likely to show a lack of direction after moving sharply higher over the past several sessions...
Stocks showed a strong move to the upside during trading on Monday, extending the rally seen to close out the previous week. With the continued advance, the major averages reached their best...
Revenue of $1.099 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $167 Million Adjusted EBITDA (non-GAAP)1 of $180 Million Revenue Grew 18% as Reported and 20% on a Constant...
21 Poster Presentations include Evaluations of Consumer, Pharmaceutical, Surgical and Vision Care Products and Pipeline Programs, Including a Novel Dry Eye Nutritional Supplement Bausch + Lomb...
Novel Supplement Shown to Address Signs and Symptoms of Dry Eyes, All Primary Endpoints Achieved Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE and Biotrue® Eye Care...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter 2024 financial results on...
Presentations Will Feature Studies Evaluating TENEO™ Excimer Laser Platform, MIEBO® (Perfluorohexyloctane Ophthalmic Solution) and enVista® Envy* and IC-8® Apthera™ IOLs Bausch + Lomb Corporation...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.1 | 0.684931506849 | 14.6 | 15.5 | 14.465 | 656863 | 15.00276666 | CS |
4 | 0.805 | 5.79345088161 | 13.895 | 15.5 | 13.16 | 608064 | 14.44551931 | CS |
12 | 0.39 | 2.72536687631 | 14.31 | 17.695 | 13.16 | 540831 | 15.43314063 | CS |
26 | -1.5 | -9.25925925926 | 16.2 | 17.695 | 13.16 | 549609 | 15.34177929 | CS |
52 | -4 | -21.3903743316 | 18.7 | 21.95 | 13.16 | 501728 | 16.74844403 | CS |
156 | -3.8 | -20.5405405405 | 18.5 | 21.95 | 12.2 | 620339 | 16.38069112 | CS |
260 | -3.8 | -20.5405405405 | 18.5 | 21.95 | 12.2 | 620339 | 16.38069112 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions